LBF20406LT02: Difference between revisions

No edit summary
No edit summary
Line 13: Line 13:
|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR(250MHz, D<SUB><FONT SIZE=-1>2</FONT></SUB>O) : <FONT FACE="Symbol">d</FONT> 6.45(m, 1H, 8-CH), 6.15(m, 2H, 9,10-CH), 6.0(m, 1H, 7-CH), 5.65(m, 1H, 11-CH), 5.40(m, 1H, 15-CH), 5.25(m, 2H, 6,14-CH), 4.60(5-CH), 4.05(m, 1H, 12-CH), 2.15(m, 2H, 13-CH), 2.00(m, 1H, 2-CH), 1.85(m, 2H, 16-CH), 1.35-1.60(m, 4H, 3,4-CH), 1.00-1.25(m, 6H, 17,18,19-CH), 0.70(m, 3H, 20-CH) [[Reference:Merrer_YL:Gravier-Pelletier_C:Micas-Languin_D:Mestre_F:Durreault_A:Depezay_JC:,J. Org. Chem.,1989,54,2409|{{RelationTable/GetFirstAuthor|Reference:Merrer_YL:Gravier-Pelletier_C:Micas-Languin_D:Mestre_F:Durreault_A:Depezay_JC:,J. Org. Chem.,1989,54,2409}}]]
|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR(250MHz, D<SUB><FONT SIZE=-1>2</FONT></SUB>O) : <FONT FACE="Symbol">d</FONT> 6.45(m, 1H, 8-CH), 6.15(m, 2H, 9,10-CH), 6.0(m, 1H, 7-CH), 5.65(m, 1H, 11-CH), 5.40(m, 1H, 15-CH), 5.25(m, 2H, 6,14-CH), 4.60(5-CH), 4.05(m, 1H, 12-CH), 2.15(m, 2H, 13-CH), 2.00(m, 1H, 2-CH), 1.85(m, 2H, 16-CH), 1.35-1.60(m, 4H, 3,4-CH), 1.00-1.25(m, 6H, 17,18,19-CH), 0.70(m, 3H, 20-CH) [[Reference:Merrer_YL:Gravier-Pelletier_C:Micas-Languin_D:Mestre_F:Durreault_A:Depezay_JC:,J. Org. Chem.,1989,54,2409|{{RelationTable/GetFirstAuthor|Reference:Merrer_YL:Gravier-Pelletier_C:Micas-Languin_D:Mestre_F:Durreault_A:Depezay_JC:,J. Org. Chem.,1989,54,2409}}]]
|Source=Leukotriene B4 is produced by polymorphonuclear leukocytes and macrophages of various animal species upon various stimulations on the cells [[Reference:Samuelsson_B:Hammarstrom_S:,Vitam. Horm.,1982,39,1|{{RelationTable/GetFirstAuthor|Reference:Samuelsson_B:Hammarstrom_S:,Vitam. Horm.,1982,39,1}}]][[Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355|{{RelationTable/GetFirstAuthor|Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355}}]];>.
|Source=Leukotriene B4 is produced by polymorphonuclear leukocytes and macrophages of various animal species upon various stimulations on the cells [[Reference:Samuelsson_B:Hammarstrom_S:,Vitam. Horm.,1982,39,1|{{RelationTable/GetFirstAuthor|Reference:Samuelsson_B:Hammarstrom_S:,Vitam. Horm.,1982,39,1}}]][[Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355|{{RelationTable/GetFirstAuthor|Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355}}]];>.
|Chemical Synthesis=[[Reference:Corey_EJ:Marfat_A:Goto_G:Brion_F:,J. Am. Chem. Soc.,1980,102,7984|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Marfat_A:Goto_G:Brion_F:,J. Am. Chem. Soc.,1980,102,7984}}]];> {{Image200|XPR3101FT0001.gif}}
|Chemical Synthesis=[[Reference:Corey_EJ:Marfat_A:Goto_G:Brion_F:,J. Am. Chem. Soc.,1980,102,7984|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Marfat_A:Goto_G:Brion_F:,J. Am. Chem. Soc.,1980,102,7984}}]];> {{Image200|LBF20406LT02FT0001.gif}}
|Metabolism=Arachidonic acid is metabolized to leukotrienen A4 with 5,6-epoxide by 5-lipoxygenases, and the product is further transformed to leukotrienee B4 by leukotriene A hydrolase [[Reference:Ford-Hutchinson_AW:Gresser_M:Young_RN:,Annu. Rev. Biochem.,1994,63,383|{{RelationTable/GetFirstAuthor|Reference:Ford-Hutchinson_AW:Gresser_M:Young_RN:,Annu. Rev. Biochem.,1994,63,383}}]];>. Leukotriene B4 is metabolized to lose its bioactivities either by <FONT FACE="Symbol">w</FONT>-oxidation [[Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355|{{RelationTable/GetFirstAuthor|Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355}}]];> or by leukotriene B4 12-hydroxydehydrogenase [[Reference:Yokomizo_T:Izumi_T:Takahashi_T:Kasama_T:Kobayashi_Y:Sato_F:Taketani_Y:Shimizu_T:,J. Biol. Chem.,1993,268,18128|{{RelationTable/GetFirstAuthor|Reference:Yokomizo_T:Izumi_T:Takahashi_T:Kasama_T:Kobayashi_Y:Sato_F:Taketani_Y:Shimizu_T:,J. Biol. Chem.,1993,268,18128}}]];>.
|Metabolism=Arachidonic acid is metabolized to leukotrienen A4 with 5,6-epoxide by 5-lipoxygenases, and the product is further transformed to leukotrienee B4 by leukotriene A hydrolase [[Reference:Ford-Hutchinson_AW:Gresser_M:Young_RN:,Annu. Rev. Biochem.,1994,63,383|{{RelationTable/GetFirstAuthor|Reference:Ford-Hutchinson_AW:Gresser_M:Young_RN:,Annu. Rev. Biochem.,1994,63,383}}]];>. Leukotriene B4 is metabolized to lose its bioactivities either by <FONT FACE="Symbol">w</FONT>-oxidation [[Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355|{{RelationTable/GetFirstAuthor|Reference:Hammarstrom_S:,Annu. Rev. Biochem.,1983,52,355}}]];> or by leukotriene B4 12-hydroxydehydrogenase [[Reference:Yokomizo_T:Izumi_T:Takahashi_T:Kasama_T:Kobayashi_Y:Sato_F:Taketani_Y:Shimizu_T:,J. Biol. Chem.,1993,268,18128|{{RelationTable/GetFirstAuthor|Reference:Yokomizo_T:Izumi_T:Takahashi_T:Kasama_T:Kobayashi_Y:Sato_F:Taketani_Y:Shimizu_T:,J. Biol. Chem.,1993,268,18128}}]];>.
}}
}}


{{Lipid/Footer}}
{{Lipid/Footer}}

Revision as of 10:00, 25 November 2009

LipidBank Top
(トップ) 		Fatty acid
(脂肪酸) 		Glycerolipid
(グリセロ脂質) 		Sphingolipid
(スフィンゴ脂質) 		Journals
(雑誌一覧) 		How to edit
(ページの書き方)


Upper classes: LB LBF



IDs and Links
LipidBank XPR3101
LipidMaps LMFA03020001
CAS
KEGG {{{KEGG}}}
KNApSAcK {{{KNApSAcK}}}
mol LBF20406LT02
LEUKOTRIENE B4
LBF20406LT02.png
Structural Information
5 (S) ,12 (R) -Dihydroxyeicosa-6 (Z) ,8 (E) ,10 (E) ,14 (Z) -tetraenoic acid
  • LEUKOTRIENE B4
  • 5 (S) ,12 (R) -Dihydroxyeicosa-6 (Z) ,8 (E) ,10 (E) ,14 (Z) -tetraenoic acid
Formula C20H32O4
Exact Mass 336.23005951199997
Average Mass 336.46567999999996
SMILES C(CC=CC[C@H](C=CC=CC=C[C@H](CCCC(O)=O)O)O)CCC
Physicochemical Information
METHANOL Corey_EJ et al.
Leukotriene B4 is produced by polymorphonuclear leukocytes and macrophages of various animal species upon various stimulations on the cells Samuelsson_B et al. Hammarstrom_S ;>.
Corey_EJ et al.;>
LBF20406LT02FT0001.gif
 Arachidonic acid is metabolized to leukotrienen A4 with 5,6-epoxide by 5-lipoxygenases, and the product is further transformed to leukotrienee B4 by leukotriene A hydrolase Ford-Hutchinson_AW et al.;>. Leukotriene B4 is metabolized to lose its bioactivities either by w-oxidation Hammarstrom_S ;> or by leukotriene B4 12-hydroxydehydrogenase Yokomizo_T et al.;>.
Spectral Information
Mass Spectra m/e 336, 319, 301 Yergey_JA et al.
UV Spectra METHANOL : 260(e 38,000), 270.5(e 50,000), 281(e 39,000)nm Corey_EJ et al.
IR Spectra
NMR Spectra 1H-NMR(250MHz, D2O) : d 6.45(m, 1H, 8-CH), 6.15(m, 2H, 9,10-CH), 6.0(m, 1H, 7-CH), 5.65(m, 1H, 11-CH), 5.40(m, 1H, 15-CH), 5.25(m, 2H, 6,14-CH), 4.60(5-CH), 4.05(m, 1H, 12-CH), 2.15(m, 2H, 13-CH), 2.00(m, 1H, 2-CH), 1.85(m, 2H, 16-CH), 1.35-1.60(m, 4H, 3,4-CH), 1.00-1.25(m, 6H, 17,18,19-CH), 0.70(m, 3H, 20-CH) Merrer_YL et al.
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20406LT02 See above. Corey_EJ et al. 1980
n.a. LBF20406LT02 See above. Ford-Hutchinson_AW et al. 1994
n.a. LBF20406LT02 See above. Funk_CD 1993
n.a. LBF20406LT02 See above. Hammarstrom_S 1983
n.a. LBF20406LT02 See above. Merrer_YL et al. 1989
n.a. LBF20406LT02 See above. Samuelsson_B et al. 1982
n.a. LBF20406LT02 See above. Sumimoto_H et al. 1984
n.a. LBF20406LT02 See above. Yergey_JA et al. 1986
n.a. LBF20406LT02 See above. Yokomizo_T et al. 1997
n.a. LBF20406LT02 See above. Yokomizo_T et al. 1993
n.a. LBF20406LT02 See above. Yokomizo_T et al. 1996


Retrieved from "http://lipidbank.jp/mediawiki/index.php?title=LBF20406LT02&oldid=55681"